Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: Effects of smoking status

Schizophrenia Research

Volumn 114, Issue 1-3, 2009, Pages 91-97

  Rabin, Rachel A ^a   Sacco, Kristi A ^c   George, Tony P ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Cigarette smoking; Neurocognition; Non smoker; Prepulse inhibition; Schizophrenia; Smoking status; Vulnerability; Wisconsin Card Sorting Test

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PERSEVERATION; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SPATIAL MEMORY; TOBACCO DEPENDENCE; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

ACOUSTIC STIMULATION; ADULT; ANALYSIS OF VARIANCE; COTININE; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; STARTLE REACTION; STATISTICS AS TOPIC; TIME FACTORS;

EID: 69849103367     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.07.006     Document Type: Article

References (42)

1. Benowitz N.L., Jacob III P., Ahijevich K., Jarvis M.J., Hall S., LeHouzec J., Lichenstein E., Henningfield J., Tsoh J., Hurt R.D., and Velicer W. Biochemical verification of tobacco use and cessation. Report from the SRNT Subcommittee on Biochemical Verification. Nicotine Tob. Res. 4 (2002) 149-159
2. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47 2 (1990) 181-188
3. Braff D.L., Grillon C., and Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry 49 (1992) 206-215
4. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001) 234-258
5. Connors C.K. The Continuous Performance Test (CPT) (1995), Psychological Assessment Resources, Inc., Odessa, FL
6. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76 (2005) 135-157
7. Depatie L., Driscoll G.A., Holahan A.L.V., Atkinson V., Thavundayil J.X., Ying Kin N.N., and Samarthji L. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27 (2002) 1056-1070
8. El Hamaoui Y., Elyazaji M., Yaalaoui S., Rachidi L., Saoud M., d'Amato T., et al. Wisconsin card sorting task in patients with schizophrenia and their siblings. Can. J. Psychiatry 51 (2006) 48-54
9. First M.B. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (DSM-IV) (1994), American Psychiatric Association, Washington, D.C.
10. George T.P. Neurobiological links between nicotine addiction and schizophrenia. J. Dual Diagnosis 3 3/4 (2007) 27-42
11. George T.P., Verrico C.D., Picciotto M.R., and Roth R.H. Nicotinic modulation of mesoprefrontal dopamine systems: pharmacologic and neuroanatomic characterization. J. Pharmacol. Exp. Ther. 295 1 (2000) 58-66
12. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., and Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26 (2002) 75-85
13. George T.P., Termine A., Sacco K.A., Seyal A.A., Dudas M.M., Allen T.M., Vessicchio J.C., and Duncan E.J. Effects of cigarette smoking on prepulse inhibition in schizophrenia: Involvement of nicotinic receptor mechanisms. Schizophr. Res. 87 (2006) 307-315
14. Goldberg T.F., and Weinberger D.R. Probing prefrontal function in schizophrenia with neuropsychological paradigms. Schizophr. Res. 14 (1988) 179-183
15. Hariharan M., VanNoord T.J., and Greden J.F. A high performance liquid chromatographic method for routine simulataneous determination of nicotine and cotinine in plasma. Clin. Chem. 34 (1988) 724-729
16. Harris J.G., Kongs S., Allensworth D., Martin L., Tregellas J., Sullivan B., Zerbe G., and Freedman R. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29 (2004) 1378-1385
17. Heaton R.K., Chelune G.J., Talley J.L., et al. Wisconsin Card Sorting Test. Manual (1993), Psychological Assessment Resources, Odessa, FL
18. Heyder K., Suchan B., et al. Cortico-subcortical contributions to executive control. Acta Psychol. (Amst) 115 2-3 (2004) 271-289
19. Kalman D., Morrisette S.B., and George T.P. Co-morbidity of smoking with psychiatric and substance use disorders. Am. J. Addict. 14 (2005) 106-123
20. Keefe R.S.E., Lees Roitman S.E., Harvey P.D., Blum C.S., DuPre R.L., Prieto R.M., Davidson M., and Davis K.L. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. Schizophr. Res. 17 (1995) 25-33
21. Knable M.B., and Weinberger D.R. Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmacol. 11 2 (1997) 123-131
22. Kumari V., and Postma P. Nicotine use in schizophrenia: the self medication hypothesis. Neurosci. Biobehav. Rev. 29 (2005) 1021-1034
23. Kumari V., Soni W., and Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum. Psychopharmacol. 16 (2001) 321-326
24. Kumari V., Gray J.A., Geyer M.A., Effytche D., Soni W., Mitterschiffthaler M.T., et al. Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatr. Res. 122 (2003) 99-113
25. Kumari V., Antonova E., et al. Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage 26 4 (2005) 1052-1058
26. Levin E.D., Wilson W., Rose J., and McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15 (1996) 429-436
27. Morice R., and Delahunty A. Frontal/executive impairments in schizophrenia. Schizophr. Bull. 22 (1996) 125-137
28. Park S., and Holzman P.S. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry 49 12 (1992) 975-982
29. Rogers R.D., Andrews T.C., et al. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J. Cogn. Neurosci. 12 1 (2000) 142-162
30. Sacco K.A., Bannon K.L., and George T.P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J. Psychopharmacol. 18 4 (2004) 457-474
31. Sacco K.A., Termine A., Seyal A.A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., and George T.P. Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 62 (2005) 649-659
32. Sacco K.A., Termine A., Dudas M.M., Seyal A.A., Allen T.M., Vessicchio J.C., Wexler B.E., and George T.P. Neuropsychological deficits in non-smokers with schizophrenia: effect of a nicotinic antagonist. Schizophr. Res. 85 (2006) 213-221
33. Sacco K.A., Creeden C.L., Reutenauer E.L., and George T.P. Effects of galantamine on neurocognitive deficits in smokers and non-smokers with schizophrenia. Schizophr. Res. 103 (2008) 326-327
34. Sacco K.A., Creeden C.L., Reutenauer E.L., Vessicchio J.C., Weinberger A.H., and George T.P. Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia. Schizophr. Res. 107 (2009) 332-333
35. Shipley W.C., and Burlington C.C. A convenient self-administered scale for measuring intellectual impairment in psychotics. Am. J. Psychiatry 97 (1941) 1313-1325
36. Smith R.C., Singh A., Infante M., Khandat A., and Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27 (2002) 479-497
37. Smith R.C., Warner-Cohen J., Matute M., Butler E., Kelly E., Vaidhyanathaswamy S., and Khan A. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31 (2006) 637-643
38. Swerdlow N.R., Geyer M.A., et al. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156 2-3 (2001) 194-215
39. Vezina P., Blanc G., et al. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J. Pharmacol. Exp. Ther. 261 2 (1992) 484-490
40. Wexler B.E., Stevens A.A., et al. Word and tone working memory deficits in schizophrenia. Arch. Gen. Psychiatry 55 12 (1998) 1093-1096
41. Williams J.M., Gandhi K.K., Steinberg M.L., Foulds J., Ziedonis D.M., and Benowitz N.L. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob. Res. 9 (2007) 873-881
42. Woznica A.A., Sacco K.A., and George T.P. Prepulse inhibition in patients with schizophrenia and controls: effects of smoking status. Schizophr. Res. 112 (2009) 86-90